TrialAnnals of surgery2012

Assessment of prognostic circulating tumor cells in a phase III trial of adjuvant immunotherapy after complete resection of stage IV melanoma.

Sojun Hoshimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.